Sensus Healthcare, Inc. Cash and Equivalents

Quick Answer

Sensus Healthcare, Inc. reported Cash and Equivalents of $22.08 million for fiscal year 2025.

Sensus Healthcare, Inc. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $22.08M +0.1%
2024 $22.06M -4.7%
2023 $23.15M -9.3%
2022 $25.52M +75.8%
2021 $14.52M -2.6%
2020 $14.91M +84.0%
2019 $8.10M -35.1%
2018 $12.48M +23.8%
2017 $10.09M +100.0%
2016 $5.04M -0.4%
2015 $5.07M +11.6%
2014 $4.54M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $24.45M +8.4% +10.3%
June 30, 2025 $22.16M +16.8% +16.2%
March 31, 2025 $19.07M +29.5% -13.5%
December 31, 2024 $22.06M -4.7% -2.2%
September 30, 2024 $22.56M +10.1% +18.9%
June 30, 2024 $18.97M -5.4% +28.8%
March 31, 2024 $14.73M -23.8% -36.4%
December 31, 2023 $23.15M -9.3% +13.0%
  • Sensus Healthcare, Inc. showed an increase of +0.1% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2014–2025 period, Sensus Healthcare, Inc.’s cash and equivalents has grown by 386.5% (from $4.54 million to $22.08 million).
  • The most recent figure is from Sensus Healthcare, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 4, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment